Gerosciences Center for Brain Health and Metabolism (GERO), Santiago, Chile.
Memory and Neuropsychiatric Center (CMYN) Neurology Department, Hospital del Salvador & Faculty of Medicine, University of Chile, Santiago, Chile.
J Alzheimers Dis. 2024;99(4):1187-1205. doi: 10.3233/JAD-230376.
Dementia is a syndrome characterized by cognitive and neuropsychiatric symptoms associated with progressive functional decline (FD). FD is a core diagnostic criterion for dementia, setting the threshold between its prodromal stages and the full-blown disease. The operationalization of FD continues to generate a great deal of controversy. For instance, the threshold of FD for the diagnosis of dementia varies across diagnostic criteria, supporting the need for standardization of this construct. Moreover, there is a need to reconsider how we are measuring FD to set boundaries between normal aging, mild cognitive impairment, and dementia. In this paper, we propose a multidimensional framework that addresses outstanding issues in the assessment of FD: i) What activities of daily living (ADLs) are necessary to sustain an independent living in aging? ii) How to assess FD in individuals with suspected neurocognitive disorders? iii) To whom is the assessment directed? and iv) How much does FD differentiate healthy aging from mild and major neurocognitive disorders? Importantly, the To Whom Question introduces a person-centered approach that regards patients and caregivers as active agents in the assessment process of FD. Thus, once impaired ADLs have been identified, patients can indicate how significant such impairments are for them in daily life. We envisage that this new framework will guide future strategies to enhance functional assessment and treatment of patients with dementia and their caregivers.
痴呆是一种以认知和神经精神症状为特征的综合征,与进行性功能下降(FD)有关。FD 是痴呆的核心诊断标准,将其前驱期和完全发病期区分开来。FD 的操作化仍然存在很大争议。例如,用于痴呆诊断的 FD 阈值因诊断标准而异,支持对这一概念进行标准化的需要。此外,需要重新考虑我们如何衡量 FD,以确定正常衰老、轻度认知障碍和痴呆之间的界限。在本文中,我们提出了一个多维框架,以解决 FD 评估中的突出问题:i)维持衰老过程中的独立生活需要哪些日常生活活动(ADL)?ii)如何评估疑似神经认知障碍个体的 FD?iii)评估对象是谁?iv)FD 在多大程度上区分健康衰老与轻度和重度神经认知障碍?重要的是,“To Whom 问题”引入了一种以患者和照护者为中心的方法,将他们视为 FD 评估过程中的积极参与者。因此,一旦确定了受损的 ADL,患者可以表明这些损伤对他们日常生活的影响有多大。我们设想,这个新框架将指导未来的策略,以增强痴呆患者及其照护者的功能评估和治疗。